Report on the 1998 financial year

Report this content

Report on the 1998 financial year (Göteborg, 24 February 1999) The Nobel Biocare Group * Sales increased by +22.6% to total SEK 1,309.7 million (1,068.2). * Operating income excluding non-recurring items increased by 48% to SEK 121.5 million (82.2). * Nobel Biocare acquired the leading US dental implant company Steri-Oss in September 1998. The integration of Steri-Oss is going well and in accordance with plan. * Sales growth of Business Area Procera® reached 189%, with a total revenue of SEK 139.5 million (48.4). * The profit per share after tax was SEK 1.88 compared with SEK 5.15 in 1997. * The Board of Directors proposes that the dividend should be increased to SEK 1.70 per share (1.55). ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/1999/02/24/19990701BIT00050/bit0001.doc http://www.bit.se/bitonline/1999/02/24/19990701BIT00050/bit0002.pdf

Documents & Links